Astragaloside IV ameliorates allergic inflammation by inhibiting key initiating factors in the initial stage of sensitization

To illuminate the anti-allergy mechanism of astragaloside IV (AS-IV), we assessed its effects in a murine model of allergic contact dermatitis (ACD). AS-IV administered in the sensitization phase, rather than in the elicitation phase, dramatically alleviated the symptoms of allergic inflammation. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Kai-fan, Yu, Xi, Wei, Xiao, Gui, Li-li, Liu, Hai-liang, Wang, Xiao-yu, Tao, Yu, Jiang, Guo-rong, Hong, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137013/
https://www.ncbi.nlm.nih.gov/pubmed/27917896
http://dx.doi.org/10.1038/srep38241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137013/
https://www.ncbi.nlm.nih.gov/pubmed/27917896
http://dx.doi.org/10.1038/srep38241

Ejemplares similares